Advertisement
Product › Details
D360 drug discovery software platform
Next higher product group | drug discovery software_o | |
Status | 2013-10-17 sales existent | |
Organisation | Certara L.P. | |
Group | Vector Capital | |
Record changed: 2017-04-01 |
Advertisement
More documents for drug discovery software_o
- [1] Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge....
- [2] Alterome Therapeutics, Inc.. (11/2/22). "Press Release: Alterome Therapeutics Extends Series A to Nearly $100 Million to Advance Alteration-Specific Cancer Therapies". San Diego, CA....
- [3] Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge....
- [4] Merck KGaA. (12/6/18). "Press Release: Merck in Agreement with Cyclica for AI-augmented Screening Platform to Expand Research Capabilities". Darmstadt....
- [5] Cyclica Inc.. (11/26/18). "Press Release: Cyclica Drives Drug Discovery through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer". Toronto....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top